A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin.

Saved in:
Bibliographic Details
Title: A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin.
Authors: Olatoke O; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Zah V; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Stanicic F; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Vukicevic D; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Yfantopoulos P; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Thompson C; Medical Department, Collegium Pharmaceutical Inc., Stoughton, MA, USA., DeGeorge MK; Medical Department, Collegium Pharmaceutical Inc., Stoughton, MA, USA., Passik S; Medical Department, Collegium Pharmaceutical Inc., Stoughton, MA, USA.
Source: ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2022 Mar 03; Vol. 14, pp. 119-128. Date of Electronic Publication: 2022 Mar 03 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101560564 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6981 (Print) Linking ISSN: 11786981 NLM ISO Abbreviation: Clinicoecon Outcomes Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1178-6981
DOI:10.2147/CEOR.S340290